Immunogenicity Assessment of Biosimilars: A Multidisciplinary Perspective
- 14 December 2018
- book chapter
- Published by Springer Nature
- p. 489-542
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- Targeting Antigens to Dendritic Cell Receptors for Vaccine DevelopmentJournal of Drug Delivery, 2013
- Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator RituximabBioDrugs, 2013
- Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent mannerAnnals of the Rheumatic Diseases, 2012
- Role of the Methoxy Group in Immune Responses to mPEG-Protein ConjugatesBioconjugate Chemistry, 2012
- Tungsten-Induced Denaturation and Aggregation of Epoetin Alfa During Primary Packaging as a Cause of ImmunogenicityPharmaceutical Research, 2011
- Trace Levels of Innate Immune Response Modulating Impurities (IIRMIs) Synergize to Break Tolerance to Therapeutic ProteinsPLOS ONE, 2010
- Visual representation of National Institute of Allergy and Infectious Disease and Food Allergy and Anaphylaxis Network criteria for anaphylaxisInternational Journal of Emergency Medicine, 2009
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-GalactoseNew England Journal of Medicine, 2008
- Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2007
- Pure Red-Cell Aplasia and Epoetin TherapyNew England Journal of Medicine, 2004